Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-Oct-24 8:32 PM View:  | Vaxcyte, Inc. (PCVX) | 07-Oct-24 | Private Sale (Planned) | 7,098 | $109.21 | $775,154.00 | (< 1%) 734.48K to 727.38K | |
| 03-Oct-24 4:17 PM View: | Vaxcyte, Inc. (PCVX) | 01-Oct-24 | Option Exercise | 40,000 | $5.35 | $214,000.00 | 5% 749.48K to 789.48K | |
| 03-Oct-24 4:17 PM View: | Vaxcyte, Inc. (PCVX) | 01-Oct-24 | Planned Option Sale | 40,000 | $114.25 | $4,570,080.00 | (5%) 789.48K to 749.48K | |
| 03-Oct-24 4:17 PM View: | Vaxcyte, Inc. (PCVX) | 01-Oct-24 | Sale (Planned) | 15,000 | $114.25 | $1,713,780.00 | (2%) 749.48K to 734.48K | |
| 05-Sep-24 5:18 PM View: | Vaxcyte, Inc. (PCVX) | 03-Sep-24 | Payment of Exercise | 13,669 | $110.15 | $1,505,640.00 | (2%) 763.15K to 749.48K | |
| 26-Aug-24 4:58 PM View: | Vaxcyte, Inc. (PCVX) | 23-Aug-24 | Option Exercise | 15,000 | $2.03 | $30,450.00 | 2% 763.15K to 778.15K | |
| 26-Aug-24 4:58 PM View: | Vaxcyte, Inc. (PCVX) | 23-Aug-24 | Planned Option Sale | 15,000 | $78.98 | $1,184,770.00 | (2%) 778.15K to 763.15K | |
| 05-Aug-24 4:08 PM View: | Vaxcyte, Inc. (PCVX) | 01-Aug-24 | Private Sale (Planned) | 2,616 | $78.79 | $206,122.00 | (< 1%) 765.76K to 763.15K | |
| 24-Jul-24 5:44 PM View: | Vaxcyte, Inc. (PCVX) | 23-Jul-24 | Option Exercise | 15,000 | $2.03 | $30,450.00 | 2% 765.76K to 780.76K | |
| 24-Jul-24 5:44 PM View: | Vaxcyte, Inc. (PCVX) | 23-Jul-24 | Planned Option Sale | 15,000 | $84.26 | $1,263,910.00 | (2%) 780.76K to 765.76K | |
| 25-Jun-24 4:43 PM View: | Vaxcyte, Inc. (PCVX) | 24-Jun-24 | Option Exercise | 15,000 | $2.03 | $30,450.00 | 2% 768.38K to 783.38K | |
| 25-Jun-24 4:43 PM View: | Vaxcyte, Inc. (PCVX) | 24-Jun-24 | Planned Option Sale | 15,000 | $75.64 | $1,134,580.00 | (2%) 783.38K to 768.38K | |
| 05-Jun-24 4:56 PM View: | Vaxcyte, Inc. (PCVX) | 03-Jun-24 | Private Sale (Planned) | 2,616 | $72.06 | $188,512.00 | (< 1%) 771.0K to 768.38K | |
| 28-May-24 10:00 PM View: | Vaxcyte, Inc. (PCVX) | 23-May-24 | Option Exercise | 15,000 | $2.03 | $30,450.00 | 2% 769.96K to 784.96K | |
| 28-May-24 10:00 PM View: | Vaxcyte, Inc. (PCVX) | 23-May-24 | Planned Option Sale | 15,000 | $69.43 | $1,041,410.00 | (2%) 784.96K to 769.96K | |
| 03-May-24 4:18 PM View: | Vaxcyte, Inc. (PCVX) | 01-May-24 | Private Sale (Planned) | 2,616 | $61.70 | $161,419.00 | (< 1%) 772.57K to 769.96K | |
| 25-Apr-24 4:52 PM View: | Vaxcyte, Inc. (PCVX) | 23-Apr-24 | Option Exercise | 15,000 | $1.79 | $26,850.00 | 2% 772.57K to 787.57K | |
| 25-Apr-24 4:52 PM View: | Vaxcyte, Inc. (PCVX) | 23-Apr-24 | Planned Option Sale | 15,000 | $61.92 | $928,845.00 | (2%) 787.57K to 772.57K | |
| 03-Apr-24 4:21 PM View: | Vaxcyte, Inc. (PCVX) | 01-Apr-24 | Private Sale (Planned) | 2,616 | $66.71 | $174,502.00 | (< 1%) 775.19K to 772.57K | |
| 27-Mar-24 4:44 PM View: | Vaxcyte, Inc. (PCVX) | 25-Mar-24 | Option Exercise | 15,000 | $1.79 | $26,850.00 | 2% 775.19K to 790.19K | |
| 27-Mar-24 4:44 PM View: | Vaxcyte, Inc. (PCVX) | 25-Mar-24 | Planned Option Sale | 15,000 | $66.93 | $1,003,980.00 | (2%) 790.19K to 775.19K | |
| 13-Mar-24 4:22 PM View: | Vaxcyte, Inc. (PCVX) | 11-Mar-24 | Option Exercise | 65,000 | $2.03 | $131,950.00 | 9% 710.19K to 775.19K | |
| 04-Mar-24 9:19 PM View: | Vaxcyte, Inc. (PCVX) | 02-Mar-24 | Payment of Exercise | 7,967 | $71.55 | $570,039.00 | (1%) 718.15K to 710.19K | |
| 04-Mar-24 9:19 PM View: | Vaxcyte, Inc. (PCVX) | 01-Mar-24 | Sale (Planned) | 2,616 | $73.70 | $192,799.00 | (< 1%) 720.77K to 718.15K | |
| 04-Mar-24 9:19 PM View: | Vaxcyte, Inc. (PCVX) | 29-Feb-24 | Grant | 45,000 | -- | -- | 7% 675.77K to 720.77K | |
| 27-Feb-24 4:17 PM View: | Vaxcyte, Inc. (PCVX) | 26-Feb-24 | Option Exercise | 30,000 | $1.79 | $53,700.00 | 4% 675.77K to 705.77K | |
| 27-Feb-24 4:17 PM View: | Vaxcyte, Inc. (PCVX) | 26-Feb-24 | Planned Option Sale | 30,000 | $79.03 | $2,370,900.00 | (4%) 705.77K to 675.77K | |
| 27-Feb-24 4:17 PM View: | Vaxcyte, Inc. (PCVX) | 23-Feb-24 | Option Exercise | 15,000 | $1.79 | $26,850.00 | 2% 675.77K to 690.77K | |
| 27-Feb-24 4:17 PM View: | Vaxcyte, Inc. (PCVX) | 23-Feb-24 | Planned Option Sale | 15,000 | $76.21 | $1,143,210.00 | (2%) 690.77K to 675.77K | |
| 05-Feb-24 5:33 PM View: | Vaxcyte, Inc. (PCVX) | 01-Feb-24 | Private Sale (Planned) | 2,616 | $73.91 | $193,353.00 | (< 1%) 678.39K to 675.77K | |
| 31-Jan-24 4:11 PM View: | Vaxcyte, Inc. (PCVX) | 29-Jan-24 | Option Exercise | 30,000 | $1.79 | $53,700.00 | 4% 678.39K to 708.39K | |
| 31-Jan-24 4:11 PM View: | Vaxcyte, Inc. (PCVX) | 29-Jan-24 | Planned Option Sale | 30,000 | $66.03 | $1,980,900.00 | (4%) 708.39K to 678.39K | |
| 25-Jan-24 5:50 PM View: | Vaxcyte, Inc. (PCVX) | 23-Jan-24 | Option Exercise | 15,000 | $1.44 | $21,600.00 | 2% 678.39K to 693.39K | |
| 25-Jan-24 5:50 PM View: | Vaxcyte, Inc. (PCVX) | 23-Jan-24 | Planned Option Sale | 15,000 | $63.92 | $958,783.00 | (2%) 693.39K to 678.39K | |
| 04-Jan-24 4:24 PM View: | Vaxcyte, Inc. (PCVX) | 02-Jan-24 | Private Sale (Planned) | 2,616 | $63.89 | $167,144.00 | (< 1%) 681.0K to 678.39K | |
| 27-Dec-23 4:35 PM View: | Vaxcyte, Inc. (PCVX) | 26-Dec-23 | Option Exercise | 10,000 | $0.04 | $400.00 | 1% 686.0K to 696.0K | |
| 27-Dec-23 4:35 PM View: | Vaxcyte, Inc. (PCVX) | 26-Dec-23 | Planned Option Sale | 15,000 | $61.70 | $925,538.00 | (2%) 696.0K to 681.0K | |
| 27-Dec-23 4:35 PM View: | Vaxcyte, Inc. (PCVX) | 22-Dec-23 | Option Exercise | 9,900 | $2.03 | $20,097.00 | 1% 676.1K to 686.0K | |
| 05-Dec-23 4:15 PM View: | Vaxcyte, Inc. (PCVX) | 01-Dec-23 | Private Sale (Planned) | 2,618 | $52.12 | $136,442.00 | (< 1%) 678.72K to 676.1K | |
| 28-Nov-23 4:50 PM View: | Vaxcyte, Inc. (PCVX) | 24-Nov-23 | Private Sale (Planned) | 15,000 | $49.09 | $736,300.00 | (2%) 693.72K to 678.72K | |
| 03-Nov-23 4:29 PM View: | Vaxcyte, Inc. (PCVX) | 01-Nov-23 | Private Sale (Planned) | 2,618 | $47.29 | $123,813.00 | (< 1%) 696.34K to 693.72K | |
| 25-Oct-23 4:07 PM View: | Vaxcyte, Inc. (PCVX) | 23-Oct-23 | Private Sale (Planned) | 15,000 | $47.07 | $706,070.00 | (2%) 711.34K to 696.34K | |
| 04-Oct-23 4:06 PM View: | Vaxcyte, Inc. (PCVX) | 02-Oct-23 | Private Sale (Planned) | 2,618 | $50.42 | $131,996.00 | (< 1%) 713.96K to 711.34K | |
| 27-Sep-23 4:54 PM View: | Vaxcyte, Inc. (PCVX) | 25-Sep-23 | Private Sale (Planned) | 15,000 | $52.45 | $786,794.00 | (2%) 731.57K to 716.57K | |
| 27-Sep-23 4:54 PM View: | Vaxcyte, Inc. (PCVX) | 25-Sep-23 | Sale (Planned) | 2,618 | $52.43 | $137,264.00 | (< 1%) 716.57K to 713.96K | |
| 06-Sep-23 5:33 PM View: | Vaxcyte, Inc. (PCVX) | 05-Sep-23 | Payment of Exercise | 10,378 | $51.00 | $529,278.00 | (1%) 741.95K to 731.57K | |
| 31-Mar-23 4:36 PM View: | Athira Pharma, Inc. (ATHA) | 30-Mar-23 | Purchase | 15,000 | $2.47 | $37,050.00 | 139% 10.78K to 25.78K | |
| 31-Mar-23 4:36 PM View: | Athira Pharma, Inc. (ATHA) | 29-Mar-23 | Private Purchase | 10,000 | $2.33 | $23,300.00 | 1277% 0.78K to 10.78K | |
| 03-Mar-23 5:09 PM View: | Vaxcyte, Inc. (PCVX) | 02-Mar-23 | Payment of Exercise | 3,099 | $41.49 | $128,578.00 | (< 1%) 744.01K to 740.91K | |
| 03-Mar-23 5:09 PM View: | Vaxcyte, Inc. (PCVX) | 01-Mar-23 | Grant | 53,875 | -- | -- | 8% 690.14K to 744.01K |